Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Katherine Marie Harris, MD, Michael Keller, MD, Catherine M. Bollard, MD, Sarah Horn, BA, Christopher Lazarski, PhD, Gelina Sani, MS

Blood (2019) 134 (Supplement_1): 3251.

https://doi.org/10.1182/blood-2019-131898

Published: 2019

Journal Articles

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia a Patients Entering Routine Clinical Treatment with Nuwiq ® , Octanate ® or Wilate ® — the Protect-NOW Study

Johannes Oldenburg, MD PhD, Anna Pavlova, MD PhD, Susan Halimeh, MD, Robert Klamroth, Joris Versteden, Martina Jansen, Larisa Belyanskaya, PhD

Blood (2018) 132 (Supplement 1): 5034.

https://doi.org/10.1182/blood-2018-99-116577

Published: 2018

Journal Articles

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Shabnum Patel, PhD, Shuroug Albihani, Elizabeth Williams, Julia Sung, Conrad Russell Young Cruz, MD PhD, R. Brad Jones, PhD, Elizabeth J Shpall, MD, David Margolis, Richard F Ambinder, MD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2017) 130 (Supplement 1): 1010.

https://doi.org/10.1182/blood.V130.Suppl_1.1010.1010

Published: 2017

Journal Articles

Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)

Paul Moorehead, MD, Mark J. Belletrutti, MD MSc, David Lillicrap, MD FRCPC, Robert J Klaassen, MD FRCPC, Manuel Carcao, MDMSc, Georges E. Rivard, MD FRCPC

Blood (2017) 130 (Supplement 1): 3679.

https://doi.org/10.1182/blood.V130.Suppl_1.3679.3679

Published: 2017

Journal Articles

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Shannon L. Meeks, MD, Courtney Cox, MSc, W. Hunter Baldwin, BS

Blood (2017) 130 (Supplement 1): 2364.

https://doi.org/10.1182/blood.V130.Suppl_1.2364.2364

Published: 2017

Journal Articles

Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies

Satyen Harish Gohil, MBBS MRCP FRCPath, Marco Della Peruta, PhD, Solange R Paredes-Moscosso, Micaela Harrasser, Gordon Weng-Kit Cheung, MSc, David M Davies, PhD, Martin A Pule, MD PhD, Amit C Nathwani, MD PhD

Blood (2016) 128 (22): 3361.

https://doi.org/10.1182/blood.V128.22.3361.3361

Published: 2016

Journal Articles

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

Solange R Paredes-Moscosso, Marco Della Peruta, PhD, Satyen Harish Gohil, MBBS MRCP FRCPath, Micaela Harrasser, Amit C Nathwani, MD PhD

Blood (2016) 128 (22): 2052.

https://doi.org/10.1182/blood.V128.22.2052.2052

Published: 2016

Journal Articles

A Novel Monoclonal Antibody Against A2 Domain of Von Willebrand Factor Reduces Its Proteolysis By ADAMTS13

Lulu Zhang, Jian Su, Fei Shen, Zhenni MA, Yiming Zhao, Ziqiang Yu, Changgeng Ruan

Blood (2016) 128 (22): 2575.

https://doi.org/10.1182/blood.V128.22.2575.2575

Published: 2016

Journal Articles

Mapping T-Cell Peptide Epitopes on Activated Recombinant Factor VII (rFVIIa) Contributing to Inhibitor Antibody Response

Pedro Paz, Jens Schroeder, Prasad Mathew, Marion Hardtke, Fred Aswad

Blood (2015) 126 (23): 2295.

https://doi.org/10.1182/blood.V126.23.2295.2295

Published: 2015

Journal Articles

Identification of B Cell Receptor Antigens in the Chronic Lymphocytic Leukemia Microenvironment

Elisa ten Hacken, PhD, Thomas Oellerich, MD, Maria Gounari, PhD, Julia Hoellenriegel, MS, Kuan-Ting Pan, PhD, Susan O'Brien, MD, William Wierda, MD PhD, Alessandra Ferrajoli, MD, Zeev Estrov, MD, Michael J. Keating, MD, Henning Urlaub, PhD, Paolo Ghia, MD PhD, Jan A. Burger, MD PhD

Blood (2015) 126 (23): 2922.

https://doi.org/10.1182/blood.V126.23.2922.2922

Published: 2015

Journal Articles

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Joerg Kahle, PhD, Aleksander Orlowski, Anja Schmidt, PhD, Kerstin Brettschneider, Thomas Klingebiel, MD, John F Healey, BS, Ernest T Parker, BA, John (Pete) S Lollar, MD, Marc Jacquemin, MD, Manuela Krause, MD, Andreas Tiede, MD PhD, Dirk Schwabe, MD, Christoph Königs, MD PhD

Blood (2015) 126 (23): 3491.

https://doi.org/10.1182/blood.V126.23.3491.3491

Published: 2015

Journal Articles

The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors

Margaret A. Robinson, B.A., Courtney Cox, M.S., Wallace Hunter Baldwin, Philip Zakas, Shannon L Meeks, MD

Blood (2014) 124 (21): 2837.

https://doi.org/10.1182/blood.V124.21.2837.2837

Published: 2014

Journal Articles

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Tami Livnat, PhD, Amy Dunn, Shirley Azar- Avivi, Courtney Cox, Einat Avishai, Shannon L. Meeks, MD, Gili Kenet, MD

Blood (2014) 124 (21): 2841.

https://doi.org/10.1182/blood.V124.21.2841.2841

Published: 2014

Journal Articles

Identification of the Antigenic Targets of the Major CLL-Derived Stereotyped BCRs and First Demonstration of Sub-Subsets

Klaus-Dieter Preuss, Natalie Fadle, Evi Regitz, Maria Kemele, Manuela Wölfle, Stephan Stilgenbauer, MD, Michael Pfreundschuh, Prof MD

Blood (2014) 124 (21): 298.

https://doi.org/10.1182/blood.V124.21.298.298

Published: 2014

Journal Articles

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Paul A. Castillo, MD, Jan J Melenhorst, PhD, Patrick J Hanley, PhD, Michael Keller, MD, Robert A. Krance, MD, Judith Margolin, MD, Ann Leen, PhD, Helen E. Heslop, MD, John Barrett, MD, Cliona M Rooney, PhD, Catherine M. Bollard, MD FRACP, FRCPA

Blood (2014) 124 (21): 2439.

https://doi.org/10.1182/blood.V124.21.2439.2439

Published: 2014

Journal Articles

Assessing Structure-Activity Relationships in FVIII By Integration of Structural, Biophysical, and Biochemical Data Obtained with Anti-FVIII Antibodies

Zhiqian Lucy Liu, PhD, George Bou-Assaf, PhD, Ming Zhang, PhD, Allison Goodman, Po-lin Chiu, PhD, Melissa Chambers, Thomas Walz, PhD, Robert Peters, PhD, John Kulman, PhD

Blood (2014) 124 (21): 4223.

https://doi.org/10.1182/blood.V124.21.4223.4223

Published: 2014

Journal Articles

Screening for Potential HLA-DRB1-Restricted T-Cell Epitopes in Factor VIII Using Peptide Microarrays

Debargh Dutta, PhD, Maochang Liu, PhD, Devi Gunasekera, MD, Kenneth B. Lewis, PhD, Eddie A. James, PhD, Kathleen P. Pratt, PhD

Blood (2014) 124 (21): 1506.

https://doi.org/10.1182/blood.V124.21.1506.1506

Published: 2014

Journal Articles

Engineered FVIII-Specific Human T-Effector Cells: Can the T-Cell Receptor Modulate CD4 + T-Helper Phenotypes or Is It Just a “Switch”?

Patrick Adair, Yong Chan Kim, PhD, Kathleen P. Pratt, PhD, David W Scott, PhD

Blood (2014) 124 (21): 1417.

https://doi.org/10.1182/blood.V124.21.1417.1417

Published: 2014

Journal Articles

Autoantibody Epitope Mapping By Hydrogen-Deuterium Exchange Mass Spectrometry at Nearly Single Amino Acid Residue Resolution Reveals Novel Exosites on ADAMTS13 Critical for Substrate Recognition and Mechanism of Autoimmune Thrombotic Thrombocytopenic Purpura

Veronica C. Casina, PhD, Wenbing Hu, PhD, Hayley A. Hanby, B.S., Brandy Pickens, PhD, Leland Mayne, PhD, Eric Ostertag, MD, PhD, Stephen Kacir, PhD, Don L. Siegel, MD, PhD, S. Walter Englander, PhD, X. Long Zheng, MD, PhD

Blood (2014) 124 (21): 108.

https://doi.org/10.1182/blood.V124.21.108.108

Published: 2014

Journal Articles

Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)

Adam D. Cohen, MD, Nikoletta Lendvai, MDPhD, Sacha Gnjatic, PhD, Achim A Jungbluth, MD, Stephane Bertolini, Linda Pan, Pharm.D., Ralph Venhaus, Ioanna Tsakos, Katarzyna Garcia, MS, Linda Thibodeau, RN, Katherine Alpaugh, PhD, Nailah Cummings, Rafik Fellague-Chebra, MD, Olivier Gruselle, Hearn J. Cho, MD PhD

Blood (2014) 124 (21): 1184.

https://doi.org/10.1182/blood.V124.21.1184.1184

Published: 2014

NARROW

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia a Patients Entering Routine Clinical Treatment with Nuwiq ® , Octanate ® or Wilate ® — the Protect-NOW Study

Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT

Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

A Novel Monoclonal Antibody Against A2 Domain of Von Willebrand Factor Reduces Its Proteolysis By ADAMTS13

Mapping T-Cell Peptide Epitopes on Activated Recombinant Factor VII (rFVIIa) Contributing to Inhibitor Antibody Response

Identification of B Cell Receptor Antigens in the Chronic Lymphocytic Leukemia Microenvironment

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors

Beyond the Bethesda Assay- Towards Individualized Interpretation of Inhibitor Patients' FVIII Brand Specific Profiles

Identification of the Antigenic Targets of the Major CLL-Derived Stereotyped BCRs and First Demonstration of Sub-Subsets

Graft Versus Leukemia Response without Graft Versus Host Disease Elicited By Adoptively Transferred Multivirus-Specific T-Cells

Assessing Structure-Activity Relationships in FVIII By Integration of Structural, Biophysical, and Biochemical Data Obtained with Anti-FVIII Antibodies

Screening for Potential HLA-DRB1-Restricted T-Cell Epitopes in Factor VIII Using Peptide Microarrays

Engineered FVIII-Specific Human T-Effector Cells: Can the T-Cell Receptor Modulate CD4 + T-Helper Phenotypes or Is It Just a “Switch”?

Autoantibody Epitope Mapping By Hydrogen-Deuterium Exchange Mass Spectrometry at Nearly Single Amino Acid Residue Resolution Reveals Novel Exosites on ADAMTS13 Critical for Substrate Recognition and Mechanism of Autoimmune Thrombotic Thrombocytopenic Purpura

Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only